TY - JOUR
T1 - Resumen ejecutivo de ARIA 2019: Vías integradas de atención para la rinitis alérgica en Argentina, España y México
AU - Ivancevich, Juan Carlos
AU - Cardona, Victoria
AU - Larenas-Linnemann, D. sirée
AU - Mullol, Joaquim
AU - Neffen, Hugo
AU - Zernotti, Mario
AU - Asayag, Estrella
AU - Blua, Ariel Eduardo
AU - Gómez, R. Maximiliano
AU - Jares, Edgardo
AU - Máspero, Jorge
AU - Anto, Josep M.
AU - Dedeu, Toni
AU - Rodríguez-González, M. nica
AU - Huerta-Villalobos, Yunuen Rocío
AU - Fuentes-Pérez, José Miguel
AU - Rodríguez-Zagal, Eréndira
AU - Valero, Antonio
AU - Bartra, Joan
AU - Alobid, Isam
AU - Castillo-Vizuete, José Antonio
AU - Dordal, Teresa
AU - Hijano, Rafael
AU - Picado, C. sar
AU - Sastre, Joaquín
AU - Bedolla-Barajas, Martín
AU - Burguete-Cabañas, María Teresa
AU - Costa-Domínguez, María Del Carmen
AU - Domínguez-Silva, Margarita
AU - Espinoza-Contreras, Jesús Guillermo
AU - Gálvez-Romero, José Luis
AU - García-Cobas, Cecilia Yvonne
AU - García-Cruz, María de la Luz Hortensia
AU - Hernández-Velázquez, Luiana
AU - Luna-Pech, Jorge A.
AU - Matta, Juan José
AU - Mogica-Martínez, María Dolores
AU - Rivero-Yeverino, Daniela
AU - Ruiz, Lucy Tania
AU - del Río-Navarro, Blanca E.
AU - Gómez-Vera, Javier
AU - Macías-Weinmann, Alejandra
AU - Agache, Ionna
AU - Ansotegui, Ignacio
AU - Bachert, Claus
AU - Bedbrook, Anna
AU - Canonica, Giorgio Walter
AU - Casale, Thomas B.
AU - Cruz, Álvaro
AU - Fokkens, Wytske
AU - Hellings, Peter
AU - Samolinski, Bolesław
AU - Bousquet, Jean
PY - 2019
Y1 - 2019
N2 - The health and economic impact of allergic diseases are increasing rapidly, and changes in management strategies are required. Its influence reduces the capacity of work and school performance by at least a third. The ICPs of the airways (integrated care pathways for respiratory diseases) are structured multidisciplinary healthcare plans, promoting the recommendations of the guidelines in local protocols and their application to clinical practice. This document presents an executive summary for Argentina, Mexico, and Spain. Next-generation ARIA guidelines are being developed for the pharmacological treatment of allergic rhinitis (AR), using the GRADE-based guidelines for AR, tested with real-life evidence provided by mobile technology with visual analogue scales. It is concluded that in the AR treatment, H1-antihistamines are less effective than intranasal corticosteroids (INCS), in severe AR the INCS represent the first line of treatment, and intranasal combination INCS + anti-H1 is more effective than monotherapy. However, according to the MASK real-life observational study, patients have poor adherence to treatment and often self-medicate, according to their needs.
AB - The health and economic impact of allergic diseases are increasing rapidly, and changes in management strategies are required. Its influence reduces the capacity of work and school performance by at least a third. The ICPs of the airways (integrated care pathways for respiratory diseases) are structured multidisciplinary healthcare plans, promoting the recommendations of the guidelines in local protocols and their application to clinical practice. This document presents an executive summary for Argentina, Mexico, and Spain. Next-generation ARIA guidelines are being developed for the pharmacological treatment of allergic rhinitis (AR), using the GRADE-based guidelines for AR, tested with real-life evidence provided by mobile technology with visual analogue scales. It is concluded that in the AR treatment, H1-antihistamines are less effective than intranasal corticosteroids (INCS), in severe AR the INCS represent the first line of treatment, and intranasal combination INCS + anti-H1 is more effective than monotherapy. However, according to the MASK real-life observational study, patients have poor adherence to treatment and often self-medicate, according to their needs.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85081575047&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/32105425
U2 - https://doi.org/10.29262/ram.v66i4.643
DO - https://doi.org/10.29262/ram.v66i4.643
M3 - Article
C2 - 32105425
SN - 0002-5151
VL - 66
SP - 409
EP - 425
JO - Revista alergia Mexico
JF - Revista alergia Mexico
IS - 4
ER -